Product NDC: | 65862-362 |
Proprietary Name: | Lamotrigine |
Non Proprietary Name: | Lamotrigine |
Active Ingredient(s): | 25 mg/1 & nbsp; Lamotrigine |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, CHEWABLE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 65862-362 |
Labeler Name: | Aurobindo Pharma Limited |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA090401 |
Marketing Category: | ANDA |
Start Marketing Date: | 20091104 |
Package NDC: | 65862-362-01 |
Package Description: | 100 TABLET, CHEWABLE in 1 BOTTLE (65862-362-01) |
NDC Code | 65862-362-01 |
Proprietary Name | Lamotrigine |
Package Description | 100 TABLET, CHEWABLE in 1 BOTTLE (65862-362-01) |
Product NDC | 65862-362 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Lamotrigine |
Dosage Form Name | TABLET, CHEWABLE |
Route Name | ORAL |
Start Marketing Date | 20091104 |
Marketing Category Name | ANDA |
Labeler Name | Aurobindo Pharma Limited |
Substance Name | LAMOTRIGINE |
Strength Number | 25 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE],Mood Stabilizer [EPC] |